Bisoprolol detailed information: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Bisoprolol}} | {{Bisoprolol}} | ||
{{CMG}}; {{AE}} {{SS}} | {{CMG}}; {{AE}} {{SS}} | ||
'''''For patient information about Bisoprolol, click [[Bisoprolol (patient information)|here]]''''' | '''''For patient information about Bisoprolol, click [[Bisoprolol (patient information)|here]]''''' | ||
Revision as of 02:21, 4 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2] For patient information about Bisoprolol, click here
Synonyms / Brand Names: Template:ZEBETA
Overview
Bisoprolol is a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases. More specifically, it is a selective type β1 adrenergic receptor blocker [1].
Category
Cardiovascular Drugs：Beta blockers
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages